Emergent BioSolutions, Inc. (EBS)
5.17
+0.09
(+1.77%)
USD |
NYSE |
Aug 24, 16:00
5.17
0.00 (0.00%)
After-Hours: 20:00
Emergent BioSolutions Total Assets (Quarterly) : 1.117B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.117B |
| March 31, 2026 | 1.320B |
| December 31, 2025 | 1.332B |
| September 30, 2025 | 1.461B |
| June 30, 2025 | 1.417B |
| March 31, 2025 | 1.426B |
| December 31, 2024 | 1.397B |
| September 30, 2024 | 1.478B |
| June 30, 2024 | 1.514B |
| March 31, 2024 | 1.804B |
| December 31, 2023 | 1.835B |
| September 30, 2023 | 1.893B |
| June 30, 2023 | 2.179B |
| March 31, 2023 | 2.950B |
| December 31, 2022 | 3.166B |
| September 30, 2022 | 2.908B |
| June 30, 2022 | 2.735B |
| March 31, 2022 | 2.780B |
| December 31, 2021 | 2.958B |
| September 30, 2021 | 2.868B |
| June 30, 2021 | 2.915B |
| March 31, 2021 | 2.900B |
| December 31, 2020 | 2.883B |
| September 30, 2020 | 2.616B |
| June 30, 2020 | 2.466B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.279B |
| December 31, 2019 | 2.327B |
| September 30, 2019 | 2.334B |
| June 30, 2019 | 2.321B |
| March 31, 2019 | 2.154B |
| December 31, 2018 | 2.229B |
| September 30, 2018 | 1.174B |
| June 30, 2018 | 1.139B |
| March 31, 2018 | 1.068B |
| December 31, 2017 | 1.070B |
| September 30, 2017 | 1.024B |
| June 30, 2017 | 970.48M |
| March 31, 2017 | 951.64M |
| December 31, 2016 | 970.11M |
| September 30, 2016 | 932.03M |
| June 30, 2016 | 1.056B |
| March 31, 2016 | 1.036B |
| December 31, 2015 | 1.037B |
| September 30, 2015 | 976.55M |
| June 30, 2015 | 943.32M |
| March 31, 2015 | 917.84M |
| December 31, 2014 | 945.26M |
| September 30, 2014 | 869.29M |
| June 30, 2014 | 837.25M |
| March 31, 2014 | 823.25M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Exelixis, Inc. | 2.494B |
| Capricor Therapeutics, Inc. | 368.74M |
| ADMA Biologics, Inc. | 684.21M |
| Akebia Therapeutics, Inc. | 349.66M |
| Arcutis Biotherapeutics, Inc. | 488.54M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 775.40M |
| Shareholders Equity (Quarterly) | 341.40M |
| Debt to Equity Ratio | 1.723 |
| Current Ratio | 5.424 |
| Net Debt Paydown Yield | 3.93% |